Location · Tampa, FL
Clinical trials in Tampa, FL
548 recruiting studies have a site in the Tampa area, and 80 of them accept healthy volunteers. The area includes St. Petersburg, Saint Petersburg, Clearwater, Brandon, Largo, Lakeland and nearby cities.
548 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Chandler, AZ + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Biogen
- Location
- Little Rock, AR + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Boehringer Ingelheim
- Location
- Covina, CA + 78 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Boehringer Ingelheim
- Location
- Anniston, AL + 199 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Boehringer Ingelheim
- Location
- Alabaster, AL + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Liquidia Technologies, Inc.
- Location
- Phoenix, AZ + 12 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
VarmX B.V.
- Location
- Chandler, AZ + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Boehringer Ingelheim
- Location
- La Palma, CA + 15 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Regeneron Pharmaceuticals
- Location
- Dothan, AL + 42 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Boehringer Ingelheim
- Location
- Phoenix, AZ + 24 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Anaheim, CA + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Draig Therapeutics Ltd
- Location
- Phoenix, AZ + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Boehringer Ingelheim
- Location
- Birmingham, AL + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Phoenix, AZ + 35 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 4
Secukinumab Open Label Roll-over Extension Protocol
Novartis Pharmaceuticals
- Location
- Boca Raton, FL + 1 other US site
- Eligibility basics
- Ages 6–100
- RecruitingPhase 2/Phase 3
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Electra Therapeutics Inc.
- Location
- Birmingham, AL + 16 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 3
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Novartis Pharmaceuticals
- Location
- Anniston, AL + 20 other US sites
- Eligibility basics
- Ages 12–100
- RecruitingPhase 3
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Sanofi
- Location
- Palo Alto, CA + 14 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
AstraZeneca
- Location
- Alexander City, AL + 93 other US sites
- Eligibility basics
- Ages 18–130
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- Birmingham, AL + 130 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Regeneron Pharmaceuticals
- Location
- Chandler, AZ + 144 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 2
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Alto Neuroscience
- Location
- Phoenix, AZ + 38 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Cytokinetics
- Location
- Alexander City, AL + 80 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Abiomed Inc.
- Location
- Tampa, FL + 1 other US site
- Eligibility basics
- Ages 18–80